Trials / Completed
CompletedNCT03516578
CMR for Prognosis Assessment in NSTEMI
Comprehensive Cardiac Magnetic Resonance Imaging For Prognosis Assessment After Non-ST-Elevation Myocardial Infarction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 314 (actual)
- Sponsor
- Heart Center Leipzig - University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
The prognostic significance of cardiac magnetic resonance (CMR) derived parameters of myocardial and microvascular injury has not been fully elucidated yet in non-ST-Elevation myocardial infarction (NSTEMI) patients. In the present study the investigators aim to comprehensively investigate the prognostic significance of CMR in a prospective, multicentre registry cohort of NSTEMI patients undergoing early percutaneous coronary intervention (PCI). CMR will be performed within the first week following the index event. The primary endpoint is defined as a composite of death, reinfarction, and new congestive heart failure (major adverse cardiac events) at 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cardiac magnetic resonance imaging |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2018-03-28
- Completion
- 2018-03-28
- First posted
- 2018-05-04
- Last updated
- 2018-05-11
Source: ClinicalTrials.gov record NCT03516578. Inclusion in this directory is not an endorsement.